
IG4 Capital's Industrial Investment Pattern Extends to Agriculture-Adjacent Chemical Assets
IG4 Capital's broader industrial investment pattern, now including its pending Braskem stake
prodchem
Aug 28, 2026
Braskem generated approximately $12.7 billion in 2025 sales, giving chemical traders and procurement teams a clear benchmark for the scale of one of Latin America's most important petrochemical producers. The figure places Braskem among the region's major industrial chemical businesses and provides context for evaluating its position against regional peers.
The revenue number also needs to be viewed alongside difficult market conditions. Braskem reported that global oversupply, weaker petrochemical spreads and trade uncertainty continued to pressure the industry during 2025.
For buyers, this combination of large scale and challenging economics matters. A major producer can influence regional availability, pricing discussions and sourcing options even when industry margins remain under pressure.
Braskem's 2025 revenue reached approximately $12.7 billion, according to reported financial data. The company's own integrated report places 2025 net revenue at about $12.6 billion, while its reported consolidated financial statements show net sales and services revenue of R$70.7 billion.
The difference in dollar figures reflects reporting and currency conversion conventions, but the overall scale remains clear. Braskem operates as a major producer across basic petrochemicals, thermoplastic resins and other chemical products.
For procurement professionals, revenue provides a useful starting point for comparing corporate scale. However, revenue alone does not determine production capacity, profitability or influence over a specific chemical segment.
Comparing revenue helps chemical buyers understand the relative size of regional producers. A larger sales base can indicate broader geographic reach, a diversified product portfolio and a substantial customer network.
Braskem's operations span Brazil, Mexico, the United States and Europe. Its portfolio includes polyethylene, polypropylene, PVC, basic chemicals and other petrochemical products, giving the company exposure to multiple industrial value chains.
For traders, the most relevant comparison points include:
Revenue scale: Indicates the approximate commercial footprint of a producer.
Production capacity: Shows the physical ability to supply markets.
Geographic reach: Helps buyers understand sourcing and logistics options.
Product diversity: Reduces dependence on a single chemical or polymer.
Utilization rates: Indicates how effectively installed capacity is operating.
This broader view gives procurement teams more useful intelligence than revenue rankings alone.
Braskem's large revenue base does not shield it from petrochemical market cycles. The company reported that global oversupply and weak spreads continued to affect its 2025 performance.
Brazil's petrochemical industry faced particularly difficult conditions. Braskem reported that the average utilization rate of Brazil's petrochemical complexes fell to 68% in 2025, while preliminary industry data cited an average installed-capacity utilization rate of 59% for Brazil's petrochemical industry.
The weak environment also affected profitability. Braskem's recurring EBITDA for 2025 fell to $557 million, down 49% from the previous year
Revenue provides a useful benchmark, but procurement decisions require more detailed information. Buyers need to understand whether a producer can supply the required grade, volume and destination within the required timeframe.
A practical supplier assessment should include:
Product availability: Confirm current supply rather than relying on company-wide scale.
Production location: Identify the plant or region supplying the material.
Lead times: Evaluate shipping and production schedules.
Quality documentation: Confirm specifications and required certificates.
Alternative sources: Maintain qualified backup suppliers where appropriate.
Market exposure: Monitor feedstock and global polymer conditions.
This approach can help buyers use corporate financial intelligence without allowing it to replace operational sourcing analysis.
Braskem's polymer business makes its revenue particularly relevant to plastics manufacturers. The company reported annual production capacities of approximately 3.055 million tonnes for polyethylene, 1.85 million tonnes for polypropylene and 710,000 tonnes for PVC in its 2025 integrated report.
Such capacity gives Braskem a significant role in regional polymer supply. Changes in utilization, maintenance or investment can therefore influence buyers that depend on polyethylene, polypropylene or related materials.
For converters, packaging producers and industrial manufacturers, supplier diversification remains valuable even when purchasing from a major producer. Alternative origins can provide protection against temporary disruptions and strengthen negotiating positions.
Braskem's 2025 revenue demonstrates the company's scale, but its financial performance shows the difficulty of the current petrochemical cycle. The company's recurring EBITDA declined sharply while utilization rates remained under pressure.
This matters because profitability can influence future investment. Producers operating through prolonged weak margins may prioritize efficiency, cost control and balance-sheet management over aggressive capacity expansion.
For buyers, capital spending trends can therefore be more informative than revenue growth. New capacity, maintenance investment and modernization projects can have direct consequences for future supply.
Braskem's 2025 revenue should serve as a baseline rather than a static ranking. Procurement professionals can update their assessment as 2026 production, pricing and ownership developments unfold.
The most useful indicators include:
Quarterly revenue and sales volumes: These show whether commercial activity is recovering.
Utilization rates: These indicate how much installed capacity is actually operating.
Petrochemical spreads: These provide insight into producer economics.
Capital investment: Spending can reveal future capacity and efficiency priorities.
Export and import flows: Trade data can expose regional supply imbalances.
Combining these metrics can give buyers a more accurate picture of Braskem's competitive position.
Braskem's approximately $12.7 billion in 2025 sales provides a useful benchmark for assessing the scale of a major Latin American petrochemical producer. Its broad portfolio, international footprint and substantial polymer capacity make it an important reference point for regional chemical procurement.
At the same time, the company's 2025 performance shows why revenue should not stand alone. Weak petrochemical spreads, lower utilization and intense global competition can affect profitability and operating decisions even when annual sales remain substantial.
For chemical traders and procurement managers, the best strategy is to combine revenue comparisons with production capacity, utilization, trade flows and supplier reliability. This approach can reveal where genuine sourcing opportunities exist as Latin America's petrochemical market navigates a challenging cycle.

Featured Product
Found this useful?
Continue Reading

IG4 Capital's broader industrial investment pattern, now including its pending Braskem stake

Schrödinger's computational chemistry technology helped shape Ajax Therapeutics from its 2019 founding, and Lilly's acquisition now brings that platform and its JAK2 program deeper into a major pharmaceutical pipeline.

Brazilian agrochemical producers dependent on Braskem-supplied petrochemical intermediates are watching the IG4